[Essential phospholipids in the treatment of alcohol-related liver disease: clinical and experimental study].
Conducted clinical and experimental study showed the effectiveness of the use of essential phospholipids as hepatoprotector alcohol-related liver diseases. The application of essential phospholipids reduces the morphological severity of inflammatory and degenerative changes in the liver, improves the clinical picture and laboratory status of patients.
M A
MA
Butov
A S
AS
Vasilevskaia
O A
OA
Maslova
M B
MB
Mnikhovich
D000293:Adolescent; D000328:Adult; D000368:Aged; D000437:Alcoholism / Q000097:blood / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D000818:Animals; D005260:Female; D006801:Humans; D008108:Liver Diseases, Alcoholic / Q000097:blood / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D010713:Phosphatidylcholines / Q000008:administration & dosage / Q000627:therapeutic use*; D017208:Rats, Wistar; D016896:Treatment Outcome; D055815:Young Adult
D010713:Phosphatidylcholines; C011246:essential 303 forte